Taken together, our data indicate that gemcitabine has inhibitory efficacy via Drosha/DGCR8‐induced signaling and also that deregulated Drosha/DGCR8 might contribute to gemcitabine chemoresistance in PC cells. This evidence concerns the gene DROSHA and pachyonychia congenita.